Feed aggregator

Mr J Nash v Costco Wholesale UK Ltd: 3206099/2022

JCVI - Thu, 04/11/2024 - 14:54

Employment Tribunal decision.

Cérélia / Jus-Rol merger inquiry

JCVI - Thu, 04/11/2024 - 12:17

The CMA is investigating the completed acquisition by Cérélia Group Holding SAS (either directly or indirectly) of certain assets relating to the UK and Ireland dough business (Jus-Rol) of General Mills, Inc.

LC-2023-000743; Cornerstone Telecommunications Infrastructure Limited v Brendan Duffy

JCVI - Thu, 04/11/2024 - 11:05

Midlands Region Judge Barlow 07 March 2024

Assessment process and criteria

JCVI - Thu, 04/11/2024 - 09:44

This guidance explains our competition process and how your proposal is assessed.

Summary of changes

JCVI - Thu, 04/11/2024 - 09:30

Regulatory burden statement – April 2024

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2023)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2022)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2023)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2022)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2023)

JCVI - Thu, 04/11/2024 - 09:30

Subject knowledge enhancement (SKE) course directory

JCVI - Thu, 04/11/2024 - 09:30

MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report

JCVI - Thu, 04/11/2024 - 09:30

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2022)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2022)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections data (up to October to December 2021)

JCVI - Thu, 04/11/2024 - 09:30

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2023)

JCVI - Thu, 04/11/2024 - 09:30

Clostridioides difficile ribotyping network (CDRN): guide to services

JCVI - Thu, 04/11/2024 - 09:30

The CDRN laboratory provides timely access to Clostridioides difficile culture, ribotyping and DNA fingerprinting services, according to standardised submission criteria.

Mr A Naisbitt v Fortnight Ltd (in Administration) and Freedom Technology Ltd: 3313550/2023

JCVI - Thu, 04/11/2024 - 09:01

Employment Tribunal decision.

Mrs J Leino v P O'Halloran/GCA Chartered Accountants: 2302807/2023

JCVI - Thu, 04/11/2024 - 08:55

Employment Tribunal decision.

Pages